K. King

Economic value of gemcitabine compared to cisplatin and etoposide in non-small cell lung cancer.

F. A. Dorr, R. C. McDonald, C. Copley-Merriman, 1996, Lung cancer.

EORTC LCCG Phase II study of topotecan in combination with cisplatin as second line chemotherapy of sensitive and refractory small cell lung cancer (SCLC)

G. Giaccone, C. Legrand, A. Ardizzoni, 2000 .

Rationale and design of the Diet Restriction and Exercise-induced Adaptations in Metastatic breast cancer (DREAM) study: a 2-arm, parallel-group, phase II, randomized control trial of a short-term, calorie-restricted, and ketogenic diet plus exercise during intravenous chemotherapy versus usual care

Richard B. Thompson, K. Courneya, J. Mackey, 2021, BMC Cancer.

No evidence of disease versus residual disease in long-term responders to first-line HER2-targeted therapy for metastatic breast cancer

D. Cescon, Philippe Bédard, P. Tang, 2021, British Journal of Cancer.

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

R. Hyzy, D. Talmor, C. Cairns, 2017, The Lancet Respiratory Medicine.

A phase II study of topotecan given as a continuous 21-day infusion every 28 days in platinum pre-treated ovarian carcinoma

M. Gore, K. King, L. Pyle, 1997 .

A Randomized Study of Immune Plasma for the Treatment of Severe Influenza

M. Hughes, C. Cairns, J. Metcalf, 2017 .